Skip to content

Epidural Morphine Following Vaginal Delivery

Epidural Morphine Following Vaginal Delivery: A Randomised, Double-Blind, Placebo-Controlled Trial

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00803114
Enrollment
228
Registered
2008-12-05
Start date
2002-03-31
Completion date
2005-02-28
Last updated
2009-01-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain

Keywords

Postpartum perineal pain, Epidural morphine, Randomised clinical trial

Brief summary

The investigators believe that pain management following a vaginal delivery can be improved. Many women receive epidural medication during labor and delivery, and the investigators felt that using the epidural following delivery might improve the first day pain. This study is to determine whether a single dose of epidural morphine given to mothers after a vaginal delivery will reduce the perineal pain in the postpartum period.

Detailed description

Vaginal deliveries comprise 80-85% of all deliveries. Although this is felt to be natural and safe, this route can be associated with significant perineal trauma and subsequent postpartum perineal pain. The degree of perineal trauma varies from the minimum of vaginal stretching and distension associated with labor, to episiotomy and significant perineal tears. In spite of the differences in the degree of injury following vaginal delivery, postpartum pain therapy is poorly organized and at best consists of simple analgesics and anti-inflammatory drugs. The purpose of this study is to determine if a single dose of epidural-administered morphine offers additional advantage to an organized program for the management of immediate postpartum perineal pain following vaginal delivery.

Interventions

DRUGPreservative-free epidural morphine

One time dose of preservative-free epidural morphine 2.5 mg given within one hour following vaginal delivery

DRUGPlacebo

5 ml of epidural preservative-free saline given within one hour following vaginal delivery

Sponsors

The Physicians' Services Incorporated Foundation
CollaboratorOTHER
Mount Sinai Hospital, Canada
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
16 Years to 50 Years
Healthy volunteers
No

Inclusion criteria

* Healthy parturients (ASA 1 or 2) of \> 34 weeks gestational age who chose epidural analgesia for labor, and deliver vaginally.

Exclusion criteria

* Women whose labor is terminated by cesarean delivery * Parturients with known morphine allergy * Parturients with narcotic addiction past / present

Design outcomes

Primary

MeasureTime frame
The Number of Women Who Received Systemic Narcotic Analgesics in the First 24 Hours Postpartum24 hours postpartum

Secondary

MeasureTime frameDescription
Time to First Request for AnalgesiaHoursAll participants requested analgesia at least once during their hospitalization
Maternal Visual Analogue Scale (VAS) Score at Time of Request for First Additional Analgesicby 24 hours postpartumParticipants were asked to indicate on a 10 cm line the point at which their perineal pain scored between one end anchored with no pain in my bottom to the other end anchored with the worst pain in my bottom that I can imagine
Maternal Satisfaction With Perineal Pain Managementat 24 hours postpartum5 point Likert scale asking for agreement with the statement I was satisfied with my pain relief for the pain in my bottom during the first day after delivery. Scale ranged from strongly disagree to strongly agree.
Side Effectsat 24 hours postpartumNumber of participants with pruritus, nausea and vomiting, urinary retention, drowsiness in the first 24 hours postpartum

Countries

Canada

Participant flow

Recruitment details

Parturients were recruited at Mount Sinai Hospital labor and delivery unit. Recruitment took place between March 2002 and November 2004.

Pre-assignment details

Parturients were approached prior to delivery if they had received epidural analgesia for labor. Following a vaginal delivery, the subject was randomized to one of the two arms.

Participants by arm

ArmCount
Epidural Morphine
2.5 mg dose of epidural morphine given within one hour following vaginal delivery
113
Placebo
5 ml of epidural preservative-free saline given within one hour following vaginal delivery
115
Total228

Baseline characteristics

CharacteristicEpidural MorphinePlaceboTotal
Age Continuous32.1 years
STANDARD_DEVIATION 4.9
31.8 years
STANDARD_DEVIATION 4.9
32.0 years
STANDARD_DEVIATION 4.9
Maternal Body Mass Index (BMI)29.0 kg/m2
STANDARD_DEVIATION 5.9
29.0 kg/m2
STANDARD_DEVIATION 6.6
29.0 kg/m2
STANDARD_DEVIATION 6.2
Neonatal Birth Weight3.4 kilograms
STANDARD_DEVIATION 0.51
3.4 kilograms
STANDARD_DEVIATION 0.46
3.4 kilograms
STANDARD_DEVIATION 0.48
Operative vaginal delivery
Operative vaginal delivery
38 participants34 participants72 participants
Operative vaginal delivery
Spontaneous vaginal delivery
75 participants81 participants156 participants
Parity
Multiparous
37 participants36 participants73 participants
Parity
Primiparous
76 participants79 participants155 participants
Perineal Trauma
First degree tear or less
31 Participants28 Participants59 Participants
Perineal Trauma
Second degree tear or greater
82 Participants87 Participants169 Participants
Race/Ethnicity, Customized
Caucasian
87 Participants99 Participants186 Participants
Race/Ethnicity, Customized
Missing information
9 Participants5 Participants14 Participants
Race/Ethnicity, Customized
Non-caucasian
17 Participants11 Participants28 Participants
Sex: Female, Male
Female
113 Participants115 Participants228 Participants
Sex: Female, Male
Male
0 Participants0 Participants0 Participants

Outcome results

Primary

The Number of Women Who Received Systemic Narcotic Analgesics in the First 24 Hours Postpartum

Time frame: 24 hours postpartum

Population: Analysis by intention to treat.

ArmMeasureValue (NUMBER)
Epidural MorphineThe Number of Women Who Received Systemic Narcotic Analgesics in the First 24 Hours Postpartum8 participants
PlaceboThe Number of Women Who Received Systemic Narcotic Analgesics in the First 24 Hours Postpartum37 participants
Comparison: Relative risk ratio estimation with 95% CI using exact methodsp-value: 0.0595% CI: [0.12, 0.41]Fisher Exact
Secondary

Maternal Satisfaction With Perineal Pain Management

5 point Likert scale asking for agreement with the statement I was satisfied with my pain relief for the pain in my bottom during the first day after delivery. Scale ranged from strongly disagree to strongly agree.

Time frame: at 24 hours postpartum

ArmMeasureGroupValue (NUMBER)
Epidural MorphineMaternal Satisfaction With Perineal Pain ManagementStrongly Disagree1 participants
Epidural MorphineMaternal Satisfaction With Perineal Pain ManagementDisagree9 participants
Epidural MorphineMaternal Satisfaction With Perineal Pain ManagementNot sure6 participants
Epidural MorphineMaternal Satisfaction With Perineal Pain ManagementAgree43 participants
Epidural MorphineMaternal Satisfaction With Perineal Pain ManagementStrongly Agree45 participants
Epidural MorphineMaternal Satisfaction With Perineal Pain ManagementMissing information9 participants
PlaceboMaternal Satisfaction With Perineal Pain ManagementStrongly Agree45 participants
PlaceboMaternal Satisfaction With Perineal Pain ManagementStrongly Disagree3 participants
PlaceboMaternal Satisfaction With Perineal Pain ManagementAgree38 participants
PlaceboMaternal Satisfaction With Perineal Pain ManagementDisagree11 participants
PlaceboMaternal Satisfaction With Perineal Pain ManagementMissing information10 participants
PlaceboMaternal Satisfaction With Perineal Pain ManagementNot sure8 participants
p-value: 0.8Fisher Exact
Secondary

Maternal Visual Analogue Scale (VAS) Score at Time of Request for First Additional Analgesic

Participants were asked to indicate on a 10 cm line the point at which their perineal pain scored between one end anchored with no pain in my bottom to the other end anchored with the worst pain in my bottom that I can imagine

Time frame: by 24 hours postpartum

ArmMeasureValue (MEAN)Dispersion
Epidural MorphineMaternal Visual Analogue Scale (VAS) Score at Time of Request for First Additional Analgesic0.3 scores on a scaleStandard Deviation 1.4
PlaceboMaternal Visual Analogue Scale (VAS) Score at Time of Request for First Additional Analgesic1.6 scores on a scaleStandard Deviation 2.7
p-value: 0.0595% CI: [0.7, 1.8]t-test, 2 sided
Secondary

Side Effects

Number of participants with pruritus, nausea and vomiting, urinary retention, drowsiness in the first 24 hours postpartum

Time frame: at 24 hours postpartum

Secondary

Time to First Request for Analgesia

All participants requested analgesia at least once during their hospitalization

Time frame: Hours

ArmMeasureValue (MEAN)Dispersion
Epidural MorphineTime to First Request for Analgesia22.9 hoursStandard Deviation 4
PlaceboTime to First Request for Analgesia18.9 hoursStandard Deviation 8
p-value: 0.0595% CI: [-5.7, -2.3]t-test, 2 sided

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026